These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 6264793)
1. Corticoliberin activity of rat neurohypophysis is distinct from vasopressin. Kárteszi M; Stark E; Rappay G; László FA; Makara GB Am J Physiol; 1981 Jun; 240(6):E689-93. PubMed ID: 6264793 [TBL] [Abstract][Full Text] [Related]
2. Demonstration of corticotropin-releasing factor (CRF) activity in the neurohypophysis of Brattleboro rats. Kárteszi M; Makara GB; László FA; Rappay G; Stark E Ann N Y Acad Sci; 1982; 394():630-3. PubMed ID: 6983849 [No Abstract] [Full Text] [Related]
4. Central control of ACTH secretion in diabetes insipidus Brattleboro rats. Baertschi AJ; Bény JL Ann N Y Acad Sci; 1982; 394():591-606. PubMed ID: 6295235 [No Abstract] [Full Text] [Related]
5. Marked changes of arginine vasopressin, oxytocin, and corticotropin-releasing hormone in hypophysial portal plasma after pituitary stalk damage in the rat. Makara GB; Sutton S; Otto S; Plotsky PM Endocrinology; 1995 May; 136(5):1864-8. PubMed ID: 7720631 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor. Muret L; Priou A; Oliver C; Grino M Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of dynamics of corticotropin-releasing factor (CRF) activity in the rat hypothalamus under stress]. Fujieda K Hokkaido Igaku Zasshi; 1976 May; 51(3):199-216. PubMed ID: 184025 [TBL] [Abstract][Full Text] [Related]
8. Ovine corticotropin-releasing factor and vasopressin: antibody-quenching studies on hypothalamic extracts of normal and Brattleboro rats. Linton EA; Gillies GE; Lowry PJ Endocrinology; 1983 Nov; 113(5):1878-83. PubMed ID: 6605243 [TBL] [Abstract][Full Text] [Related]
9. Corticoliberin (CRF) activity of the rat neurohypophysis. Kárteszi M; Stark E; Makara GB; Fazekas I; Rappay G Endocrinol Exp; 1978 Dec; 12(4):204-8. PubMed ID: 220011 [TBL] [Abstract][Full Text] [Related]
10. Use of the reverse hemolytic plaque assay to study the regulation of anterior lobe adrenocorticotropin (ACTH) secretion by ACTH-releasing factor, arginine vasopressin, angiotensin II, and glucocorticoids. Childs GV; Burke JA Endocrinology; 1987 Feb; 120(2):439-44. PubMed ID: 3026776 [TBL] [Abstract][Full Text] [Related]
11. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF. Bruhn TO; Plotsky PM; Vale WW Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350 [TBL] [Abstract][Full Text] [Related]
12. Effect of electrical stimulation of the neurohypophysis on ACTH release in rats with hypothalamic lesions. Makara GB; Stark E; Kárteszi M; Fellinger E; Rappay G; Szabó D Neuroendocrinology; 1980 Oct; 31(4):237-43. PubMed ID: 6252493 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of dithiothreitol and iodoacetamide on corticotropin-releasing factor (CRF) activity of bovine hypothalamic CRFs and vasopressin. Yasuda N; Aizawa T; Greer MA Endocrinology; 1982 Jun; 110(6):2074-80. PubMed ID: 6280987 [TBL] [Abstract][Full Text] [Related]
14. Release of corticotropin and corticotropin-releasing factors from rat posterior pituitary in vitro. Bény JL; Baertschi AJ Neuroendocrinology; 1980; 30(2):108-12. PubMed ID: 6243758 [TBL] [Abstract][Full Text] [Related]
15. Comparison of adrenocorticotropin control in Brattleboro, Long-Evans, and Wistar rats. Measurement of corticotropin-releasing factor, arginine vasopressin, and oxytocin in hypophysial portal blood. Tannahill LA; Dow RC; Fairhall KM; Robinson IC; Fink G Neuroendocrinology; 1988 Dec; 48(6):650-7. PubMed ID: 2855106 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of hypothalamic corticotropin releasing activity by vasopressin: studies in the Brattleboro rat. Buckingham JC Ann N Y Acad Sci; 1982; 394():580-6. PubMed ID: 6295234 [No Abstract] [Full Text] [Related]
17. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin. Grino M; Paulmyer-Lacroix O; Faudon M; Renard M; Anglade G Endocrinology; 1994 Dec; 135(6):2549-57. PubMed ID: 7988443 [TBL] [Abstract][Full Text] [Related]
18. [Effects of electric stimulation of the para-ventricular nucleus on corticotropin function in Long-Evans and Brattleboro rats]. Rey M; Conte-Devolx B; Grillo JM; Castanas E; Mercier G; Boudouresque F; Giraud P; Millet Y; Oliver C C R Seances Acad Sci III; 1982 Dec; 295(12):697-9. PubMed ID: 6301653 [TBL] [Abstract][Full Text] [Related]
19. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536 [TBL] [Abstract][Full Text] [Related]
20. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway. Kakui N; Kitamura K Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]